Environmentally determined genetic expression: clinical correlates with molecular variants of carbamyl phosphate synthetase I. (Q44819557)

6 December 2017

Environmentally determined genetic expression: clinical correlates with molecular variants of carbamyl phosphate synthetase I. (English)

1 reference

6 December 2017

6

Asha Kallianpur

1 reference

6 December 2017

1

Marshall L Summar

1 reference

6 December 2017

4

Frederick Barr

1 reference

6 December 2017

17

Gary Cunningham

1 reference

6 December 2017

Lynn Hall

2

1 reference

6 December 2017

Brian Christman

3

1 reference

6 December 2017

Heidi Smith

5

1 reference

6 December 2017

Nancy Brown

7

1 reference

6 December 2017

Meeta Yadav

8

1 reference

6 December 2017

Alecia Willis

9

1 reference

6 December 2017

Angela Eeds

10

1 reference

6 December 2017

Emma Cermak

11

1 reference

6 December 2017

Samantha Summar

12

1 reference

6 December 2017

Ann Wilson

13

1 reference

6 December 2017

Molly Arvin

14

1 reference

6 December 2017

Allison Putnam

15

1 reference

6 December 2017

Melissa Wills

16

1 reference

6 December 2017

1 April 2004

1 reference

Molecular Genetics and Metabolism

6 December 2017

1 reference

6 December 2017

81 Suppl 1

1 reference

6 December 2017

S12-9

1 reference

Mammalian urea cycle enzymes

6 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.11.014

Carbamoyl phosphate synthetase I of human liver. Purification, some properties and immunological cross-reactivity with the rat liver enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.11.014

Physical location of the site for N-acetyl-L-glutamate, the allosteric activator of carbamoyl phosphate synthetase, in the 20-kilodalton COOH-terminal domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.11.014

A structure-reactivity study of the binding of acetylglutamate to carbamoyl phosphate synthetase I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.11.014

Endogenous nitric oxide and pulmonary vascular tone in the neonate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.11.014

The effect of inhaled nitric oxide on the pulmonary circulation of the neonatal pig

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.11.014

Effect of inhaled nitric oxide on endothelin-1 and cyclic guanosine 5'-monophosphate plasma concentrations in newborn infants with persistent pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.11.014

The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.11.014

eNOS 894T allele and coronary blood flow at rest and during adenosine-induced hyperemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.11.014

Neonatal pulmonary hypertension--urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.11.014

Glu298Asp endothelial nitric oxide synthase gene polymorphism interacts with environmental and dietary factors to influence endothelial function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.11.014

Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.11.014

Therapeutic implications of human endothelial nitric oxide synthase gene polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.11.014

Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.11.014

Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the Newborn

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.11.014

Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.11.014

Effect of cardiopulmonary bypass on urea cycle intermediates and nitric oxide levels after congenital heart surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.11.014

Characterization of genomic structure and polymorphisms in the human carbamyl phosphate synthetase I gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.11.014

New strategies for identifying gene-gene interactions in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.11.014

Positive association of the endothelial nitric oxide synthase gene polymorphisms with high-altitude pulmonary edema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2003.11.014

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMGME.2003.11.014

1 reference

6 December 2017

1 reference